LINGRAPHICARE AMERICA, INC. FDA Inspection Record
LINGRAPHICARE AMERICA, INC. is an FDA-registered facility (FEI 1000123978) located in PRINCETON, NJ, US. RegDataLab tracks 7 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Feb 3, 2025: Voluntary Action Indicated (VAI)
- Inspections on record
- 7 (5 VAI, 2 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 3, 2025 | Voluntary Action Indicated (VAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Design review - Lack of or inadequate procedures (21 CFR 820.30(e)) Design validation- Lack of or inadequate procedures (21 CFR 820.30(g)) Lack of or inadequate procedures (21 CFR 820.100(a)) and 2 more |
| Aug 4, 2022 | Voluntary Action Indicated (VAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Complaints (21 CFR 820.198(a)) Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a)) Lack of Written MDR Procedures (21 CFR 803.17) |
| Nov 15, 2019 | Voluntary Action Indicated (VAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Procedures not adequately established or maintained (21 CFR 820.40) Training - Lack of or inadequate procedures (21 CFR 820.25(b)) Documentation (21 CFR 820.80(e)) and 3 more |
| Feb 15, 2017 | No Action Indicated (NAI) | Procedures not adequately established or maintained (21 CFR 820.40) Training - Lack of or inadequate procedures (21 CFR 820.25(b)) Lack of or inadequate final acceptance procedures (21 CFR 820.80(d)) Documentation (21 CFR 820.80(e)) |
| Jun 24, 2014 | No Action Indicated (NAI) | Design verification - output does not meet input requirement (21 CFR 820.30(f)) Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i)) Design validation - software validation not performed (21 CFR 820.30(g)) |
| Dec 21, 2011 | Voluntary Action Indicated (VAI) | Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a)) Documentation (21 CFR 820.100(b)) |
| Apr 15, 2009 | Voluntary Action Indicated (VAI) | Training - Lack of or inadequate procedures (21 CFR 820.25(b)) Lack of or inadequate receiving acceptance procedures (21 CFR 820.80(b)) Lack of or inadequate procedures (21 CFR 820.100(a)) DMR device specifications (21 CFR 820.181(a)) and 6 more |
FDA record score
11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
5 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Feb 3, 2025 | 6 x 1 | 6 |
| Inspection classified VAI | Aug 4, 2022 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Nov 15, 2019 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Dec 21, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Apr 15, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing LINGRAPHICARE AMERICA, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check LINGRAPHICARE AMERICA, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Lingraphicare America, Inc.
- Location
- PRINCETON, NJ (US)
- Source
- device